Ferric derisomaltose
Ferric derisomaltose has been studied in 3 papers since 2023: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Jul 13, 2026: “The effects of intravenous iron on mobility in older adults following hip fracture surgery: protocol for a multicentre, parallel group,…”.
See all 3 papers on ferric derisomaltose
At a glance
28 trials, none about aging, 3 with no results posted.
- 28 trials, none about aging, 3 with no results posted
- 14 of 28 trials sponsored by its developers
- Cells1
Has ferric derisomaltose been tested in people?
0 of 28 about aging27 trials are registered, but no study of it in people has been published yet.
Approved
Jan 16, 2020Anemia, Iron-Deficiency
Repurposing
Phase 4Recruiting2 trials
Phase 4Completed6 trials
Phase 4Completed9 trials
Phase 4Completed1 trial
Phase 3Results posted2 trials
Phase 4Recruiting1 trial
All 8Fewer
Readouts due
- Nov 2026
- Apr 30, 2027
- Aug 1, 2027
- Aug 1, 2027
- Aug 1, 2027
Who is developing ferric derisomaltose?
2 companies: Pharmacosmos and Sichuan Huiyu Pharmaceutical.
Trial sponsors
Company7 trialsPhase 35,498 people
Company1 trialPhase 188 people
China-Japan Friendship Hospital
3 trialsPhase 4430 people
1 trialPhase 44,368 people
1 trialPhase 41,160 people
1 trialPhase 4300 people
1 trialPhase 4180 people
Children's Hospital Los Angeles
1 trialPhase 4120 people